ANDRES VAZQUEZ RODRIGUEZ: Open Payments
NPI 1467600866 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,161 in 52 payments from 6 companies in 2025. Trend: 2023 $1,031 · 2024 $1,007 · 2025 $1,161
Food & beverage: $1,161
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 11 | $247 |
| Janssen Pharmaceuticals, Inc | 11 | $231 |
| E.R. Squibb & Sons, L.L.C. | 9 | $202 |
| Luye Pharma (USA) Ltd. | 8 | $195 |
| Teva Pharmaceuticals USA, Inc. | 9 | $183 |
| Alkermes, Inc. | 4 | $103 |
Products named: INVEGA SUSTENNA, ERZOFRI EXTENDED-RELEASE, COBENFY, ABILIFY MAINTENA, AUSTEDO XR, ABILIFY ASIMTUFII, ARISTADA, UZEDY.
Industry payments across FL — which companies pay providers there.
